/

Batteries & E-Mobility

/

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Waltham, Massachusetts

·

Since 2003

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2003 and headquartered in Waltham, Massachusetts. With 500–1,000 employees and estimated revenue of $100–250 million, the company develops kinase inhibitor therapies targeting cancer. It holds FDA approval for QINLOCK (Ripretinib) for advanced gastrointestinal stromal tumors and maintains a pipeline in oncology. Since April 2024, Deciphera operates as a wholly owned subsidiary of Ono Pharmaceutical.

Deciphera Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

2003

Headquarters

United States flag

Waltham, Massachusetts

Employees

500-1,000

Ownership

Deciphera Pharmaceuticals at a glance

Revenue

$100-250M

Est. band

Employees

500-1,000

Founded

2003

Headquarters

Waltham, Massachusetts

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2003 and headquartered in Waltham, Massachusetts. With 500–1,000 employees and estimated revenue of $100–250 million, the company develops kinase inhibitor therapies targeting cancer. It holds FDA approval for QINLOCK (Ripretinib) for advanced gastrointestinal stromal tumors and maintains a pipeline in oncology. Since April 2024, Deciphera operates as a wholly owned subsidiary of Ono Pharmaceutical.

At a glance

Attribute

Detail

Founded

2003

Headquarters

Waltham, Massachusetts

Employees

500-1,000

Revenue

$100-250M (estimated)

Primary capability

Batteries & E-Mobility

What Deciphera Pharmaceuticals makes

Deciphera operates a proprietary switch-control kinase inhibitor platform designed to overcome resistance mechanisms and address multiple cancer-related mutations across its pipeline candidates.

Latest developments

Facilities

Deciphera Pharmaceuticals is headquartered in Waltham, Massachusetts. Public sources also reference these locations:

Company details

As a subsidiary of Ono Pharmaceutical, the company serves oncology markets globally and maintains facilities in Waltham, Massachusetts and Lawrence, Kansas. Deciphera Pharmaceuticals was founded in 2003, has an estimated 500-1,000 employees, and is headquartered in Waltham, Massachusetts.

Frequently asked questions

What does Deciphera Pharmaceuticals make?

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2003 and headquartered in Waltham, Massachusetts. With 500–1,000 employees and estimated revenue of $100–250 million, the company develops kinase inhibitor therapies targeting cancer. It holds FDA approval for QINLOCK (Ripretinib) for advanced gastrointestinal stromal tumors and maintains a pipeline in oncology. Since April 2024, Deciphera operates as a wholly owned subsidiary of Ono Pharmaceutical.

Where is Deciphera Pharmaceuticals headquartered?

Deciphera Pharmaceuticals is headquartered in Waltham, Massachusetts (200 Smith St, Waltham, Massachusetts, 02451).

When was Deciphera Pharmaceuticals founded?

Deciphera Pharmaceuticals was founded in 2003.

How big is Deciphera Pharmaceuticals?

Deciphera Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Waltham, Massachusetts (HQ)Headquarters · United States
Waltham, Massachusetts (HQ)200 Smith St, Waltham, Massachusetts, 02451, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.